Evans Bancorp (AMEX:EVBN) reported quarterly earnings of $1.06 per share which missed the analyst consensus estimate of $1.14 by 7.02 percent. This is a 16.54 percent decrease over earnings of $1.27 per share from the same period last year.
VBI Vaccines Presents Additional Biomarker Data From Phase 1/2a Study Of VBI-1901 In Recurrent GBM At The 2023 Society For Neuro-Oncology Annual Meeting
VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that additional biomarker data from the Phase 1/2a
